rhinosinusitis%20-%20acute,%20bacterial%20(pediatric)
RHINOSINUSITIS - ACUTE, BACTERIAL (PEDIATRIC)
Rhinosinusitis is the mucosal inflammation of the nose and paranasal sinuses caused by bacteria lasting >10 days for up to 4 weeks, symptoms resolve completely and may either be persistent or severe.
It is often preceded by a viral upper respiratory tract infection.
Signs & symptoms are nonspecific and it is typically difficult to differentiate from viral upper respiratory tract infection.
Streptococcus pneumoniae is the most common cause followed by nontypeable Haemophilus influenzae.

Rhinosinusitis%20-%20acute,%20bacterial%20(pediatric) Patient Education

Patient Education

  • Reassure and educate the patient/parent about the nature of upper respiratory infection (URTI) and acute bacterial rhinosinusitis (ABRS), and expected duration of illness
    • Inform patient/parent that URTI is a self-limiting disease 
    • May also inform about the details of therapy, role of antibiotics and bacterial resistance
  • Maintain adequate hydration by drinking 6-10 glasses of water/day to thin the mucus
  • Avoidance of exposure to cigarette smoke
  • Steamy baths: Inhaled steam (from a hot bath/shower) may loosen secretions
  • Apply warm facial packs (eg warm wash cloth, hot water bottle) for 5-10 minutes ≥3x/day to promote drainage of mucus and provide some localized relief
  • Consider nasal sprays, saline irrigation and mist humidification
    • There’s no difference in symptoms score when comparing isotonic with hypertonic saline, although hypertonic solutions have been shown to improve mucociliary clearance
    • Provides moisture and reduces symptoms
  • Adequate rest
  • Sleep with head elevated to promote drainage of the sinuses or lay patient on the side to ease breathing

Prevention

  • Appropriate management of allergies and viral URTI (eg frequent handwashing)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
02 Apr 2019
Using preventive zinc and micronutrient powder supplementation does not appear to improve growth in children, a recent study has found.
Audrey Abella, 14 Oct 2020
Findings from the phase IIa T1GER study revealed the therapeutic potential of the monoclonal antibody golimumab for children and young adults with type 1 diabetes (T1D).
Roshini Claire Anthony, 28 Sep 2020

A 4-week course of amoxicillin-clavulanate in children with protracted bacterial bronchitis (PBB) does not improve cough resolution rates compared with a 2-week course, according to a study from Australia. However, the longer course may significantly extend time to first cough exacerbation.